Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
81.60    3.20 (4.08%)
Bid:
79.20
Ask:
81.00
Spread: 1.80 (2.273%)
Market Cap: £110.20m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

Director/PDMR Shareholding

21 Feb 2023 10:38

RNS Number : 5851Q
Trifast PLC
21 February 2023
 

 

 

Tuesday 21 February 2023

 

 

 

Trifast plc

(the "Company")

Director/PDMR shareholding

 

The Company announces that on Monday 20 February 2023, Mr Darren Hayes-Powell, Chief Financial Officer, purchased a total of 9,333 ordinary shares of 5 pence each in the Company ("Ordinary Shares"). Mr Hayes-Powell's spouse also purchased a total of 1,825 ordinary shares of 5 pence each in the Company ("Ordinary Shares") Following these transactions, Mr. Hayes-Powell and Persons Closely Associated with him have a beneficial interest of 11,158 Ordinary Shares in the Company.

 

 

Enquiries:

Trifast plc

Christopher Morgan

Company Secretary

Tel: +44 (0) 1825 769696

www.trifast.com

 

The notifications below are made in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Darren Hayes-Powell

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

b.

LEI

213800WFIVE6RWK3CR22

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.

Nature of the transaction

Purchase of shares by Darren Hayes-Powell and purchase of shares by Darren's spouse

c.

Price(s) and volume(s)

Transaction 1 (own purchase)

Transaction 2 (partner's purchase)

Price(s)

Volume(s)

0.532p

0.540p

9,333

1,825

d.

Aggregated information

 

Transaction 1 (own purchase)

Transaction 2 (partner's purchase)

Price(s)

Aggregated Price

Aggregated Volume(s)

0.532p

0.540p

£4,965.16

£985.50

9,333

1,825

e.

Date of the transaction

20 February 2023

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFZGZZGMNGFZM
Date   Source Headline
29th Mar 20187:00 amRNSDirectorate Change
9th Mar 20182:16 pmRNSTotal Voting Rights
15th Feb 20187:00 amRNSTrading Update
1st Feb 201811:44 amRNSTotal Voting Rights
14th Nov 20177:00 amRNSHalf-yearly Financial Report-period to 30.9.17
12th Oct 20172:44 pmRNSBlock listing Interim Review
25th Sep 20177:00 amRNSTrading Update & Notice of Half-Year Results
7th Aug 20174:48 pmRNSDirector/PDMR Shareholding
27th Jul 201712:15 pmRNSStatement to shareholders - AGM & Dividend
26th Jul 20173:13 pmRNSNotification of Share Awards &Total Voting Rights
29th Jun 201710:40 amRNSBlock listing - Additional listing -June 2017
27th Jun 20173:57 pmRNS2017 Annual Financial Report and Notice of AGM
14th Jun 20171:47 pmRNSHolding(s) in Company
13th Jun 20177:00 amRNSPreliminary Results - year ended 31 March 2017
20th Apr 20177:00 amRNSTrading Update and Notice of Results
3rd Apr 20171:36 pmRNSBlock listing Interim Review
3rd Apr 20171:32 pmRNSBlock listing Interim Review
28th Mar 201712:17 pmRNSDirector/PDMR Shareholding
20th Feb 20171:42 pmRNSDirector/PDMR Shareholding & Total Voting Rights
16th Feb 20177:00 amRNSTrading update
14th Feb 20177:00 amRNSHolding(s) in Company
8th Feb 20172:26 pmRNSTotal Voting Rights
24th Jan 201711:16 amRNSHolding(s) in Company
30th Nov 20165:33 pmRNSDirector/PDMR Shareholding
16th Nov 20163:23 pmRNSTotal Voting Rights
8th Nov 20167:00 amRNS2017 Board change in April 2017
8th Nov 20167:00 amRNSHalf-Year Financial Report - six months to 30.9.16
4th Oct 20167:00 amRNSTrading Update and Notice of HY Results
3rd Oct 20167:00 amRNSBlock listing Interim Review
3rd Oct 20167:00 amRNSBlock listing Interim Review
3rd Oct 20167:00 amRNSTotal Voting Rights
15th Sep 201610:30 amRNSDirector Declaration
27th Jul 201612:44 pmRNSResult of AGM, Dividend and Statement
26th Jul 20162:41 pmRNSTotal Voting Rights
26th Jul 20162:38 pmRNSDirector/PDMR Shareholding
26th Jul 20162:37 pmRNSHolding(s) in Company
13th Jul 201610:00 amRNSShare Awards, TVR and Transaction of PDMR
30th Jun 201610:53 amRNSAnnual Financial Report
16th Jun 20168:37 amRNSHolding(s) in Company
14th Jun 20167:00 amRNSPreliminary results - year ended 31 March 2016
3rd Jun 20161:37 pmRNSTotal Voting Rights
3rd May 20167:00 amRNSTotal Voting Rights
19th Apr 20161:32 pmRNSTotal Voting Rights
19th Apr 20167:00 amRNSTrading Update and Notice of Results
1st Apr 20162:57 pmRNSBlocklisting Interim Review (SAYE Option Scheme)
1st Apr 20162:54 pmRNSBlocklisting Interim Review -( Exec Option Scheme)
1st Apr 20162:51 pmRNSTotal Voting Rights
1st Apr 20162:49 pmRNSCompany Secretary Change
29th Mar 20162:00 pmRNSHolding(s) in Company
3rd Mar 20167:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.